Neurogene Inc
For the period ended Dec 31, 2023. Filed Mar 18, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 18, 2024
NGNE$25.28-2.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 14. Principal Accountant Fees and Services
The information required by this Item is incorporated herein by reference to the information in the 2024 Proxy Statement, including under the section entitled “Proposal 3 Ratification of Independent Auditor Appointment.”
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.